Sanjay Ramakrishnan
Sher-i-Kashmir Institute of Medical Sciences(IN)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research, Delphi Technique in Research, Respiratory Support and Mechanisms
Most-Cited Works
- → Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial(2021)431 cited
- → Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial(2021)303 cited
- → Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide(2021)166 cited
- → Survival analysis of patients on maintenance hemodialysis(2014)100 cited
- → Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial(2024)86 cited
- → Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma(2020)74 cited
- → Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial(2023)64 cited
- Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma(2020)
- → Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials(2025)58 cited
- → Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis(2022)56 cited